Australia Market Overview for Gynecological Devices 2017 - MedView

Australia Market Overview for Gynecological Devices 2017 - MedView

  • May 2017 •
  • 238 pages •
  • Report ID: 4895086 •
  • Format: PDF

The full report suite on the Australian market for gynecological devices includes assisted reproduction technology, endometrial resection, uterine fibroid embolization, hysteroscopes, colposcopes, female urinary incontinence slings, pelvic organ prolapse as well as discussions on the emerging markets of laser technology and dyspareunia treatments and fluid management equipment.

General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions

The greatest market limiter within the field of gynecology is the lack of drive towards office-based procedures and resulting decreased capital investment within gynecology. Despite robust clinical evidence that in-office procedures are safer, reduce patient cost, have higher physician reimbursement, convenient scheduling and improved patient satisfaction, there is still little incentive to move away from operating theaters or medical centers for diagnostic procedures such as hysteroscopy.

Investment in high-end endoscopy devices was a predominant trend in Australian gynecology in 2016. Despite the pressures of the economy and reductions to healthcare funding, the emphasis on superior optical quality with video capabilities is enabling the market value to increase for hysteroscopy. Hysteroscopy procedures are unique in Australia because physicians are using alternative endoscopes to perform a hysteroscopy procedure. The segmentation of both rigid and flexible endoscopes, as well as flexible endoscopes (laparoscopes and cystoscopes) and video endoscopes provide a complete overview of the capital equipment used to perform hysteroscopy procedures within the field of gynecology.

Australia is an anomaly in the sense that price sensitivity is not apparent in certain markets and so extreme in others that emerging technologies have a higher barrier to entry in Australia. Fluid management equipment and non-invasive laser technology are two emerging technologies that are fueling the market value of gynecological capital equipment globally. In Australia, however, fluid management equipment sales are minimal while laser technology has yet to erode competing markets. The forecasts provided within this report demonstrate the market changes expected to occur within the reporting period.